CDK2 Antikörper
-
- Target Alle CDK2 Antikörper anzeigen
- CDK2 (Cyclin-Dependent Kinase 2 (CDK2))
-
Reaktivität
- Human, Maus, Xenopus laevis
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CDK2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunoprecipitation (IP)
- Spezifität
- Recognizes cdk2, Mr 33kD. Does not cross-react with other cdks.
- Aufreinigung
- Protein G Column
- Immunogen
- CDK2 monoclonal antibody was raised against recombinant CDK2 (Human).
- Isotyp
- IgG
- Top Product
- Discover our top product CDK2 Primärantikörper
-
anti-Cyclin-Dependent Kinase 2 (CDK2) antibody
CDK2 Reaktivität: Human, Maus WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 1A6 unconjugated
anti-Cyclin-Dependent Kinase 2 (CDK2) (AA 211-298) antibodyCDK2 Reaktivität: Human WB, ELISA, RNAi Wirt: Maus Monoclonal 2E8 unconjugated
anti-Cyclin-Dependent Kinase 2 (CDK2) antibodyCDK2 Reaktivität: Human, Affe WB, FACS, IF Wirt: Maus Monoclonal 4B4 unconjugated
anti-Cyclin-Dependent Kinase 2 (CDK2) antibodyCDK2 Reaktivität: Human WB, IHC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 2 (CDK2) (AA 197-295) antibodyCDK2 Reaktivität: Human, Maus WB, IHC, ELISA, FACS, IF Wirt: Maus Monoclonal 1A6 unconjugated
anti-Cyclin-Dependent Kinase 2 (CDK2) (AA 1-298) antibodyCDK2 Reaktivität: Human WB, IHC, ELISA, IP, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 2 (CDK2) antibodyCDK2 Reaktivität: Human, Affe WB, FACS, IF Wirt: Maus Monoclonal 1C4 unconjugated
anti-Cyclin-Dependent Kinase 2 (CDK2) (AA 81-298) antibodyCDK2 Reaktivität: Human, Maus, Ratte WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 2 (CDK2) (AA 94-198) antibodyCDK2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 2 (CDK2) (AA 93-211) antibodyCDK2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- CDK2 antibody can be used in immunohistochemistry starting at 10 μg/mL.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.1M Tris-glycine, pH 7.4, 0.15M sodium chloride, 0.05 % sodium azide, before the addition of glycerol to 30 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- As with all antibodies avoid freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store CDK2 antibody at 4 °C or -20 °C.
-
- Target
- CDK2 (Cyclin-Dependent Kinase 2 (CDK2))
- Andere Bezeichnung
- CDK2 (CDK2 Produkte)
- Synonyme
- p33(CDK2) antikoerper, A630093N05Rik antikoerper, wu:fa10c02 antikoerper, zgc:56598 antikoerper, zgc:77684 antikoerper, eg1 antikoerper, CDKN2 antikoerper, cdk2L antikoerper, cyclin dependent kinase 2 antikoerper, cyclin-dependent kinase 2 antikoerper, cyclin-dependent kinase 2 S homeolog antikoerper, CDK2 antikoerper, Cdk2 antikoerper, cdk2 antikoerper, cdk2.S antikoerper
- Hintergrund
- Cyclin-dependent kinase 2 (CDK2), a CDC2/CDK-type protein kinase, regulates cell-cycle transition from G1 to S phase. CDK2 activation requires formation of a heterodimer with cyclin A, D, or E and phosphorylation by CAK. CDK2 inhibition results from association with p21Cip1 (CDKN1A) and p27Kip1 (CDKN1B). Two alternatively spliced variants and multiple transcription initiation sites have been reported. Inhibition of CDK2 has been suggested to help prevent chemotherapy-induced alopecia in cancer patients.
- Gen-ID
- 1017
- UniProt
- P24941
- Pathways
- PI3K-Akt Signalweg, Zellzyklus, Mitotic G1-G1/S Phases, DNA Replication, M Phase, Synthesis of DNA
-
